RAS/RAF/MEK mutated high-grade serous ovarian cancer susceptible to Raf inhibition in vitro but not in vivo
2024 · Gynecologic Oncology · 0 citations
https://doi.org/10.1016/j.ygyno.2024.07.215
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
0
Citations
0
h-index
0
i10-index
Halime Meryem Soylu is an academic researcher from University of California San Diego. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Cervical Cancer and HPV Research & Anesthesia and Pain Management.
Click to start Chat